KNB — Kanabo Share Price
Last trade - 00:00- £10.53m
- £6.66m
- £0.60m
- 33
- 22
- 27
- 16
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.76 | ||
| Price to Tang. Book | 2.5 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 12.95 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -31.22% | ||
| Return on Equity | -29.55% | ||
| Operating Margin | -544.28% | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | £m | n/a | n/a | n/a | 0.07 | 0.6 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Kanabo Group plc is a United Kingdom-based patient-focused provider of digital health services and specialist medicines, including medicinal cannabis. The Company’s principal activities are the distribution and development of cannabis derived medical and wellness products. The Company is focused on the distribution of cannabis-derived products for medical patients, and non- tetrahydrocannabinol (THC) products for cannabidiol (CBD) consumers. It has conducted research and development (R&D) in order to develop cannabis extract formulas, medical-grade vaporizers and various non-smoking consumption solutions. Its clinical and validation activities, including safety and efficiency tests, are conducted in Israel. The Company operates through two segments: Primary case and Secondary case. Primary case segment is involved in the telepharma services provided by GPS. Secondary case segment is involved in the distribution and development of cannabis-derived medical and wellness products.
Directors
- David Tsur NEC (71)
- Avihu Tamir CEO (40)
- Howard Rubenstein SEC
- Uziel Danino NED (63)
- Andrew Morrison NED (60)
- Daniel Poulter NED
- Last Annual
- December 31st, 2022
- Last Interim
- June 30th, 2023
- Incorporated
- November 17th, 2016
- Public Since
- May 17th, 2017
- No. of Employees
- 20
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- London Stock Exchange
- Shares in Issue
- 632,427,870
- Address
- Churchill House, 137-139 Brent Street, LONDON, NW4 4DJ
- Web
- https://www.kanabogroup.com/investors/
- Phone
- Auditors
- PKF Littlejohn LLP
Latest News for KNB
Upcoming Events for KNB
Full Year 2023 Kanabo Group PLC Earnings Release
Kanabo Group PLC Annual Shareholders Meeting
Half Year 2024 Kanabo Group PLC Earnings Release
Similar to KNB
Alliance Pharma
London Stock Exchange
Animalcare
London Stock Exchange
Argent BioPharma
London Stock Exchange
AstraZeneca
London Stock Exchange
Beximco Pharmaceuticals
London Stock Exchange
FAQ
As of Today at 19:12 UTC, shares in Kanabo are trading at 1.67p. This share price information is delayed by 15 minutes.
Shares in Kanabo last closed at 1.67p and the price had moved by -39.45% over the past 365 days. In terms of relative price strength the Kanabo share price has underperformed the FTSE All Share Index by -39.43% over the past year.
There is no consensus recommendation for this security.
Kanabo does not currently pay a dividend.
Kanabo does not currently pay a dividend.
Kanabo does not currently pay a dividend.
To buy shares in Kanabo you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of 1.67p, shares in Kanabo had a market capitalisation of £10.53m.
Here are the trading details for Kanabo:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: KNB
Based on an overall assessment of its quality, value and momentum Kanabo is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Kanabo. Over the past six months, its share price has outperformed the FTSE All Share Index by +10.13%.
As of the last closing price of 1.67p, shares in Kanabo were trading -3.04% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Kanabo PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at 1.67p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Kanabo's management team is headed by:
- David Tsur - NEC
- Avihu Tamir - CEO
- Howard Rubenstein - SEC
- Uziel Danino - NED
- Andrew Morrison - NED
- Daniel Poulter - NED